Establishing Impurity Specifications for Antibiotics; Draft Guidance for Industry
FDA-2025-D-6130-0002Other
Comments
19
Last activity Jul 31, 2026
Deadline
Closed on Jun 23, 2026
Closed Jun 23, 2026
Net supportiSupport minus oppose · campaigns included
+63%
+63% excluding campaigns
Document
Details
The document's own metadata, straight from the source system.
- Title
- Establishing Impurity Specifications for Antibiotics; Draft Guidance for Industry
- Posted
- Apr 20, 2026
- Comment period
- Apr 20, 2026 – Jun 23, 2026
- Topics
Analysis
Overview
What the public is saying — stance, who's commenting, and the issues they raise.
Include campaigns
Stance breakdown
+63%
Net support
Support13Oppose1Other5
Aggregates include form-letter campaigns. Excluding them, net support is +63% across organic comments.
Who commented
Breakdown by commenter type.
Business
2
Individual
14
Advocacy
1
Trade association
1
Other
1
Comments over time
Weekly arrivals, stacked by stance.
Posted Apr 20, 2026Deadline Jun 23, 2026
Apr 20May 11Jun 8Jun 22Jul 27
Support13Oppose1Other5
Support × commenter type
How each type splits across stance.
Support
Oppose
Other
Individual
64%
0%
36%
Business
50%
50%
0%
Advocacy
100%
0%
0%
Trade association
100%
0%
0%
Other
100%
0%
0%
Issues raised
The docket's canonical issues. Select one to browse its comments.
Position map
Who stands where on each issue?
Every non-silent position is backed by an excerpt from the comment.
Issues shown
Choose up to five.
| Organization | Impurity limits and control strategy | Terminology and definitions |
|---|
2 organization-typed comments could not be identified.
Comments
Explorer
Every mirrored comment — filter by stance, campaign, or issue.